Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs - Real World Outcomes
Published in: Drugs - Real World Outcomes 1/2016

Open Access 01-03-2016 | Original Research Article

Prevalence of Central Nervous System Polypharmacy and Associations with Overdose and Suicide-Related Behaviors in Iraq and Afghanistan War Veterans in VA Care 2010–2011

Authors: Garen A. Collett, Kangwon Song, Carlos A. Jaramillo, Jennifer S. Potter, Erin P. Finley, Mary Jo Pugh

Published in: Drugs - Real World Outcomes | Issue 1/2016

Login to get access

Abstract

Background

The increase in the quantities of central nervous system (CNS)-acting medications prescribed has coincided with increases in overdose mortality, suicide-related behaviors, and unintentional deaths in military personnel deployed in support of the wars in Iraq and Afghanistan. Data on the extent and impact of prescribing multiple CNS drugs among Iraq and Afghanistan Veterans (IAVs) are sparse.

Objectives

We sought to identify the characteristics of IAVs with CNS polypharmacy and examine the association of CNS polypharmacy with drug overdose and suicide-related behaviors controlling for known risk factors.

Methods

This cross-sectional cohort study examined national data of Iraq and Afghanistan Veterans (N = 311,400) who used the Veterans Health Administration (VHA) during the fiscal year 2011. CNS polypharmacy was defined as five or more CNS-acting medications; drug/alcohol overdose and suicide-related behaviors were identified using ICD-9-CM codes. Demographic and clinical characteristics associated with CNS polypharmacy were identified using a multivariable logistic regression model.

Results

We found that 25,546 (8.4 %) of Iraq and Afghanistan Veterans had CNS polypharmacy. Those with only post-traumatic stress disorder (PTSD) (adjusted odds ratio (AOR) 6.50, 99 % confidence interval (CI) 5.96–7.10), only depression (AOR 6.42, 99 % CI 5.86–7.04), co-morbid PTSD and depression (AOR 12.98, 99 % CI 11.97–14.07), and co-morbid traumatic brain injury (TBI), PTSD, and depression (AOR 15.30, 99 % CI 14.00–16.73) had the highest odds of CNS polypharmacy. After controlling for these co-morbid conditions, CNS polypharmacy was significantly associated with drug/alcohol overdose and suicide-related behavior.

Conclusion

CNS polypharmacy was most strongly associated with PTSD, depression, and TBI, and independently associated with overdose and suicide-related behavior after controlling for known risk factors. These findings suggest that CNS polypharmacy may be used as an indicator of risk for adverse outcomes. Further research should evaluate whether CNS polypharmacy may be used as a trigger for evaluation of the current care provided to these individuals.
Appendix
Available only for authorised users
Literature
1.
Jeffery DD, May L, Luckey B, Balison BM, Klette KL. Use and abuse of prescribed opioids, central nervous system depressants, and stimulants among U.S. active duty military personnel in FY 2010. Mil Med. 2014;179:1141–8.CrossRefPubMed
2.
3.
4.
5.
6.
7.
Jaramillo CA, Cooper DB, Wang C-P, Tate DF, Eapen BC, York GE, et al. Subgroups of US IRAQ and Afghanistan veterans: associations with traumatic brain injury and mental health conditions. Brain Imaging Behav. 2015;9(3):445–455.CrossRefPubMed
8.
French DD, Bair MJ, Bass E, Campbell RR, Siddharthan K. Central nervous system and musculoskeletal medication profile of a veteran cohort with blast-related injuries. J Rehabil Res Dev. 2009;46:463–8.CrossRefPubMed
9.
Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA, J Am Med Assoc. 2012;307:940–7.
10.
Bernardy NC, Lund BC, Alexander B, Friedman MJ. Increased polysedative use in veterans with posttraumatic stress disorder. Pain Med Malden Mass. 2014;15:1083–90.CrossRef
11.
Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry. 2012;69:476–83.CrossRefPubMed
12.
13.
Kane RL. Understanding health care outcomes research. 2nd ed. Sudbury: Jones and Bartlett; 2006.
14.
Pugh MJ, Finley EP, Copeland LA, Wang C-P, Noel PH, Amuan ME, et al. Complex comorbidity clusters in OEF/OIF veterans: the polytrauma clinical triad and beyond. Med Care. 2014;52:172–81.CrossRefPubMed
15.
Finley EP, Bollinger M, Noël PH, Amuan ME, Copeland LA, Pugh JA, et al. A national cohort study of the association between the polytrauma clinical triad and suicide-related behavior among us veterans who served in Iraq and Afghanistan. Am J Public Health. 2015;105:380–7.CrossRefPubMed
16.
Hanlon J, Boudreau R, Roumani Y, Newman A, Ruby C, Wright R, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2009;64A:492–8.CrossRefPubMedCentral
17.
Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain Off J Am Pain Soc. 2009;10:113–30.
18.
Management of Concussion/mTBI Working Group. VA/DoD clinical practice guideline for management of concussion/mild traumatic brain injury. J Rehabil Res Dev. 2009;46:CP1–68.
19.
20.
21.
22.
Hope OA, Zeber JE, Kressin NR, Bokhour BG, Vancott AC, Cramer JA, et al. New-onset geriatric epilepsy care: race, setting of diagnosis, and choice of antiepileptic drug. Epilepsia. 2009;50:1085–93.CrossRefPubMed
23.
Buck CJ. 2010 ICD-9-CM for hospitals, volumes 1, 2 and 3. Professional ed. Maryland Heights: Saunders Elsevier; 2010.
24.
25.
Cumming G, Finch S. Inference by eye: confidence intervals and how to read pictures of data. Am Psychol. 2005;60:170–80.CrossRefPubMed
26.
Wright RM, Roumani YF, Boudreau R, Newman AB, Ruby CM, Studenski SA, et al. Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the health, aging and body composition study. J Am Geriatr Soc. 2009;57:243–50.CrossRefPubMedPubMedCentral
27.
French DD, Campbell R, Spehar A, Cunningham F, Foulis P. Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging. 2005;22:877–85.CrossRefPubMed
28.
Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther. 1997;61:331–9.CrossRefPubMed
29.
Levine JM. Common drug interactions following traumatic brain injury. J Head Trauma Rehabil. 2013;28:151–4.CrossRefPubMed
30.
Cohen BE, Shi Y, Neylan TC, Maguen S, Seal KH. Antipsychotic prescriptions in Iraq and Afghanistan veterans with posttraumatic stress disorder in Department of Veterans Affairs healthcare, 2007–2012. J Clin Psychiatry. 2015;76:406–12.CrossRefPubMed
31.
Farinde A. An examination of co-occurring conditions and management of psychotropic medication use in soldiers with traumatic brain injury. J Trauma Nurs. 2014;21:153–7.CrossRefPubMed
32.
Lew HL, Otis JD, Tun C, Kerns RD, Clark ME, Cifu DX. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad. J Rehabil Res Dev. 2009;46:697–702.CrossRefPubMed
33.
Clark ME, Walker RL, Gironda RJ, Scholten JD. Comparison of pain and emotional symptoms in soldiers with polytrauma: unique aspects of blast exposure. Pain Med Malden Mass. 2009;10:447–55.CrossRef
34.
Carlson K, Kehle S, Meis L, Greer N, MacDonald R, Rutks I, et al. The assessment and treatment of individuals with history of traumatic brain injury and post-traumatic stress disorder: a systematic review of the evidence [Internet]. Washington (DC): department of veterans affairs (US); 2009 [cited 2013 Oct 28]. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK49144/​.
35.
Poundja J, Fikretoglu D, Brunet A. The co-occurrence of posttraumatic stress disorder symptoms and pain: is depression a mediator? J Trauma Stress. 2006;19:747–51.CrossRefPubMed
36.
Shipherd JC, Keyes M, Jovanovic T, Ready DJ, Baltzell D, Worley V, et al. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Rehabil Res Dev. 2007;44:153–66.CrossRefPubMed
37.
38.
39.
Bohnert ASB, Ilgen MA, Ignacio RV, McCarthy JF, Valenstein M, Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry. 2012;169:64–70.CrossRefPubMed
40.
Brenner LA, Ignacio RV, Blow FC. Suicide and traumatic brain injury among individuals seeking veterans health administration services. J. Head Trauma Rehabil. 2011;26:257–64.CrossRefPubMed
41.
Handler SM, Hanlon JT. Detecting adverse drug events using a nursing home specific trigger tool. Ann Long Term Care Off J Am Med Dir Assoc. 2010;18:17–22.
Metadata
Title
Prevalence of Central Nervous System Polypharmacy and Associations with Overdose and Suicide-Related Behaviors in Iraq and Afghanistan War Veterans in VA Care 2010–2011
Authors
Garen A. Collett
Kangwon Song
Carlos A. Jaramillo
Jennifer S. Potter
Erin P. Finley
Mary Jo Pugh
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Drugs - Real World Outcomes / Issue 1/2016
Print ISSN: 2199-1154
Electronic ISSN: 2198-9788
DOI
https://doi.org/10.1007/s40801-015-0055-0

Other articles of this Issue 1/2016

Drugs - Real World Outcomes 1/2016 Go to the issue

Short Communication

Medicines Management, Medication Errors and Adverse Medication Events in Older People Referred to a Community Nursing Service: A Retrospective Observational Study

Original Research Article

Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical Practice

Original Research Article

Incidence of Sustained Ventricular Tachycardia in Patients with Prolonged QTc After the Administration of Azithromycin: A Retrospective Study

Original Research Article

Estimating the Economic Burden of Rheumatoid Arthritis in Taiwan Using the National Health Insurance Database

Original Research Article

Intranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two Continents

Original Research Article

Drug-Related Problems Identified in a Sample of Portuguese Institutionalised Elderly Patients and Pharmacists’ Interventions to Improve Safety and Effectiveness of Medicines